Skip to main content
COLL logo

COLL · Collegium Pharmaceutical, Inc

Track COLL — free
Market Cap
$766.03M
Shares
32.56M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
David Dieter $3,870,092
Colleen Tupper $3,515,055
Scott Dreyer $3,041,212
Thomas Smith $2,446,008
Vikram Karnani $1,715,846
Fiscal 2024
Executive Total
Vikram Karnani $10,780,125
Joseph Ciaffoni $10,689,852
Shirley Kuhlmann $3,301,296
Colleen Tupper $3,189,972
Scott Dreyer $2,791,375
Thomas Smith $2,500,083
Michael Heffernan $466,455
David Dieter
Fiscal 2023
Executive Total
Joseph Ciaffoni $9,142,924
Shirley Kuhlmann $2,874,147
Colleen Tupper $2,734,857
Scott Dreyer $2,612,380
Thomas Smith $2,044,802
Vikram Karnani
David Dieter
Michael Heffernan
Fiscal 2022
Executive Total
Joseph Ciaffoni $6,917,530
Shirley Kuhlmann $2,431,162
Colleen Tupper $2,318,904
Scott Dreyer $2,217,192
Richard Malamut $1,664,235
Thomas Smith $600,517
Vikram Karnani
Michael Heffernan
Fiscal 2021
Executive Total
Joseph Ciaffoni $7,314,335
Shirley Kuhlmann $2,394,276
Scott Dreyer $2,381,596
Colleen Tupper $2,299,575
Richard Malamut $2,057,818
Thomas Smith
Fiscal 2020
Executive Total
Joseph Ciaffoni $6,042,639
Shirley Kuhlmann $2,096,181
Richard Malamut $1,761,807
Scott Dreyer $1,716,467
Thomas Smith
Colleen Tupper

Executive changes

Person Change Filed
Thomas Smith, M.D. Terminated 2026-05-12
Scott Dreyer Terminated 2026-05-12
Key facts CIK 1267565 CUSIP 19459J104 13F (30d) 196 filings 195 filers Visit website Investor relations